Ali-el-Dein, B <br/><br/>
Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study.  [electronic resource] 

 -  British journal of urology  May 1997 
 - 731-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0007-1331 
<br/><br/><label>Standard No.: </label>10.1046/j.1464-410x.1997.00142.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Carcinoma, Transitional Cell--pathology<br/>Dose-Response Relationship, Drug<br/>Epirubicin--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant, Newborn<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--pathology<br/>Prospective Studies<br/>Urinary Bladder Neoplasms--pathology